Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.95

-0.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BulbaMan who wrote (23430)	4/10/2007 11:50:23 AM
From: keokalani'nui	Read Replies (1) of 52153

I've owned arius for years. (It was denied me as a contest entry in 2004 or 2005, before its tse listing). Don't have much to add; it's one of those dusty small investments I just can't ever seem to throw out with the semi-annual scrubbing. Over that time arius has substantially upgraded its partners and investors without an increase in value over than through dilution. Irv Weissman's m/s on reconsituting a tumor with only one (cancer) stem cell 2 years ago or so is fascinating. The STEM CELL investment story of 2005/6 is going to be in cancer anyway. Message 20894088

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next